VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Collagen metabolism in patients with bone system tumors

   
Balaba T.Ya., Zatsepin S.T., Furtseva L.N.
PubMed Id: 5317621
Year: 1971  Volume: 17  Issue: 4  Pages: 388-393
In patients with bone system tumours, disturbances in collagen metabolism are manifested by enhanced excretion of hydroxyproline with urine while the content of collagen-like protein in blood plasma remains normal. Excretion of hydroxyproline with urine in patients with benign tumours is enhanced to a lesser extent than in patients with malignant tumours of the bone-cartilage system. In patients with benign tumours of the skeleton, greatest changes in the excretion of hydroxyproline with urine were found in the case of osteoblastoclastoma. The most significant changes in patients with malignant tumours of bone system tumours were observed during osteogenic and especially paraosteal carcinoma. After removal of the tumour in postoperative period without complications, excretion of hydroxyproline with urine is normalized but in the case of metastasis, recidivation or persisting growth of tumour, hydroxyprolinuria is maintained at a high level.
Download PDF:  
Citation:

Balaba, T. Ya., Zatsepin, S. T., Furtseva, L. N. (1971). Collagen metabolism in patients with bone system tumors. Voprosy Meditsinskoi Khimii, 17(4), 388-393.
References
 1984 (vol 30)
 1983 (vol 29)
 1982 (vol 28)
 1981 (vol 27)
 1980 (vol 26)
 1979 (vol 25)
 1978 (vol 24)
 1977 (vol 23)
 1976 (vol 22)
 1975 (vol 21)
 1974 (vol 20)
 1973 (vol 19)
 1972 (vol 18)
 1971 (vol 17)
 1970 (vol 16)
 1969 (vol 15)
 1968 (vol 14)
 1967 (vol 13)
 1966 (vol 12)
 1965 (vol 11)
◄        ►